title: Treatment of methicillin-resistant Staphylococcus aureus surgical site infections.
authors.affiliation: University of Chicago Medical Center, 5841 S Maryland Ave, MC 0010, Chicago, IL 60637, USA. elena.santayana@uchospitals.edu
authors.forename: Elena M
authors.initials: EM
authors.lastname: Santayana
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Jourjy
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D017576:Daptomycin / Q000627:therapeutic use; D006801:Humans; D000069349:Linezolid; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D008911:Minocycline / Q000031:analogs & derivatives / Q000627:therapeutic use; D023303:Oxazolidinones / Q000627:therapeutic use; D011500:Protein Synthesis Inhibitors / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D000078304:Tigecycline; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D014640:Vancomycin / Q000627:therapeutic use; D000097583:Ceftaroline
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002981:Clindamycin; D017576:Daptomycin; D000069349:Linezolid; D008911:Minocycline; D023303:Oxazolidinones; D011500:Protein Synthesis Inhibitors; D000078304:Tigecycline; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014640:Vancomycin; D000097583:Ceftaroline; C443755:ceftobiprole